Zopfs, David http://orcid.org/0000-0001-9978-7453
Pinto dos Santos, Daniel
Kottlors, Jonathan
Reimer, Robert P.
Lennartz, Simon
Kloeckner, Roman
Schlaak, Max
Theurich, Sebastian
Kabbasch, Christoph
Schlamann, Marc
Große Hokamp, Nils
Funding for this research was provided by:
Cologne Clinician Scientist Program (CCSP) / Faculty of Medicine / University of Cologne (Funded by the German Research Foundation (DFG, FI 773/15-1).)
Koeln Fortune Program / Faculty of Medicine, University of Cologne (330/2020)
Article History
Received: 17 November 2021
Revised: 19 March 2022
Accepted: 26 March 2022
First Online: 7 April 2022
Declarations
:
: The scientific guarantor of this publication is Nils Große Hokamp.
: The authors of this manuscript declare relationships with the following companies:Nils Große Hokamp receives research support from Philips Healthcare unrelated to this project. NGH is on the speakers bureau of Philips Healthcare. Nils Große Hokamp is a consultant for Bristol Myers Squibb.David Zopfs and Simon Lennartz received research support from Philips Healthcare unrelated to this project.Roman Klöckner has received consultancy fees from Boston Scientific, Bristol-Myers Squibb, Guerbet, Roche, and SIRTEX and lectures fees from BTG, EISAI, Guerbet, Ipsen, Roche, Siemens, SIRTEX, and MSD Sharp & Dohme.
: No complex statistical methods were necessary for this paper.
: For a subset of 30 patients, written informed consent was obtained from every patient in the context of a different, independent prospective study, which was approved by the institutional review board (No. 16-239, University of Cologne). Otherwise, written informed consent was waived by the institutional review board due to the retrospective character.
: Institutional review board approval was obtained.
: • retrospective• diagnostic or prognostic study• performed at one institution